Clinical trial
Microembolic Signals and Cerebrospinal Fluid Markers of Neuronal Damage After Surgical Aortic Valve
NCT01319799 is registered in ClinicalTrials.gov with Sahlgrenska University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microembolic Signals and Cerebrospinal Fluid Markers of Neuronal Damage After Surgical Aortic Valve
- Lead sponsor
- Sahlgrenska University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- June 30, 2011
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis